Mitochondria & Cancer

Mitochondria are central regulators of cancer cell survival, growth, and adaptation. Beyond producing energy-rich molecules and metabolites, mitochondria coordinate with the nucleus to regulate biosynthesis, redox balance, stress responses, cell death pathways, and communication between tumor cells and their microenvironment.

Cancer metabolism is more complex than a simple shift from mitochondrial respiration to glycolysis. Although many primary solid tumors display increased glycolysis, mitochondrial oxidative phosphorylation remains an important source of cellular energy and metabolic control. In aggressive disease states, including metastasis and cancer stem-like populations, mitochondrial function and metabolic flexibility may be especially important for survival under therapeutic, metabolic, and environmental stress.

Cancer stem-like cells are associated with tumor initiation, relapse, metastasis, and resistance to therapy. Published work from National Cancer Institute investigators and collaborators showed that ClpP agonists can inhibit breast cancer stem cell function by disrupting mitochondrial homeostasis and multiple metabolic pathways required for stem-like tumor cell activity.

Madera is developing small-molecule ClpP agonists that directly activate a mitochondrial protease, disrupting mitochondrial function and impairing cancer-cell stress adaptation. This approach is distinct from conventional cytotoxic agents and therapies focused primarily on oncogenic signaling, targeting instead a mitochondrial support system used by difficult-to-treat tumors, including drug-resistant cancer cells and cancer stem-like cells.